The Supreme Court’s decision in the Glaxo case has put domestic transfer pricing on the agenda. Salman Shaheen looks at the likelihood of a reform to the Income Tax Act and the impact it may have.
Unlock this content.
The content you are trying to view is exclusive to our subscribers.